The Lancet45m
Immunogenicity and safety of a measles and rubella-containing vaccine at age 6 and 9 months in Bangladesh: an open-label, randomised trial
The data presented support use of MR vaccine at 6 months to protect young infants during measles outbreaks and in settings ...